Alzheimer’s News and Updates

Caregivers and Loved Ones must stay informed.

Alzheimer’s clue found in specific plaque June 23, 2008

Researchers have uncovered a new clue to the cause of Alzheimer’s disease.

Alzheimer's clue found in specific plaque

The brains of people with the memory-robbing form of dementia are cluttered with a plaque made up of beta-amyloid, a sticky protein. But there long has been a question whether this is a cause of the disease or a side effect. Also involved are tangles of a protein called tau; some scientists suspect this is the cause.

Now, researchers have caused Alzheimer’s symptoms in rats by injecting them with one particular form of beta-amyloid. Injections with other forms of beta-amyloid did not cause illness, which may explain why some people have beta-amyloid plaque in their brains but do not show disease symptoms.

The findings by a team led by Dr. Ganesh M. Shankar and Dr. Dennis J. Selkoe of Harvard Medical School are reported in the current online edition of the journal Nature Medicine.

The researchers used extracts from the brains of people who donated their bodies to medicine.

Forms of soluble beta-amyloid containing different numbers of molecules, as well as insoluble cores of the brain plaque, were injected into the brains of mice. There was no detectable effect from the insoluble plaque or the soluble one-molecule or three-molecule forms, the researchers found.

Don’t Miss

But the two-molecule form of soluble beta-amyloid produced characteristics of Alzheimer’s in the rats, they reported.

Those rats had impaired memory function, especially for newly learned behaviors. Studies were also done on mice and when their brains were inspected, the density brain cells were reduced by 47 percent. The beta-amyloid seemed to affect synapses, the connections between cells that are essential for communication between them.

The research, for the first time, showed the effect of a particular type of beta-amyloid in the brain, said Dr. Marcelle Morrison-Bogorad, director of the division of neuroscience at the National Institute on Aging, which helped fund the research.

It was surprising that only one of the three types had an effect, she said in a telephone interview.

Morrison-Bogorad said the findings may help explain the discovery of plaque in the brains of people who do not develop dementia. For some time, doctors have wondered why they find some brains in autopsy that are heavily coated with beta-amyloid, but the person did not have Alzheimer’s.

The answer may lie in the two types of beta-amyloid that did not cause symptoms.

Now, the question is why one has the damaging effect and not others.

“A lot of work needs to be done,” Morrison-Bogorad said. “Nature keeps sending us down paths that look straight at the beginning, but there are a lot of curves before we get to the end.”

Dr. Richard J. Hodes, director of the National Institute on Aging, said that “while more research is needed to replicate and extend these findings, this study has put yet one more piece into place in the puzzle that is Alzheimer’s.”

In addition to the Institute on Aging, the research was funded by Science Foundation Ireland, Wellcome Trust, the McKnight and Ellison foundations and the Lefler Small Grant Fund.

Story from CNN.COM

 

Alzheimer’s sufferers win landmark court appeal over denied drugs May 9, 2008

Campaigners yesterday won a landmark victory in the fight to overturn a ban on Alzheimer’s drugs for tens of thousands of patients.

The Court of Appeal decided the process used by the Government’s rationing body to ban use of the drugs – which cost only £2.50 a day – was unfair.

The case, which was supported by a Daily Mail campaign, could pave the way for the drugs to be re-instated for newly diagnosed patients with ‘mild’ symptoms of the disease.

At present, Aricept, Exelon and Reminyl are restricted to those with moderate symptoms.

Read the entire article

 

Perispinal Etanercept: Potential as an Alzheimer therapeutic March 9, 2008

I recently viewed a video that an Alzheimer’s patient has made extraordinary improvements in his cognitive skills and gait. You can view the video on www.alzheimersgroup.org. I am posting information that I locate on the drug Etanercept:

Each of the three patients I saw treated had been tested and diagnosed with probable Alzheimer’s disease by a neurologist before perispinal etanercept treatment had begun. They and their families invited me to be present during the treatment and in the interviews before and after. I noticed clinical improvement in each of the three patients within minutes following treatment. My first impression was that there was a clear, easily discernible, difference in each. They were more cheerful, more at ease, and more attentive. My impressions were the same as those shared by each of the families (please see the movie for example). This rapid turn around brought to mind the first time, now almost two decades ago[17], that I was the original witness to the remarkable overexpression of immune cytokines in activated glia in Alzheimer patients and even in fetuses and neonates with Down’s syndrome – I was amazed!

Read the Entire Article